Mantle cell lymphoma (MCL) is an aggressive and rare B-cell non-Hodgkin lymphoma classified in two clinicopathological subtypes according to SOX11 expression and mutation state of immunoglobulin variable region heavy chain (IgVH) gene. The transcription factor SOX11, overexpressed in 78%-93% of MCL patients, plays a central role inmodulating tumor microenvironment prosurvival signals and angiogenic genes. In this work, we have explored the lymph node microenvironment of three subgroups of MCL patients classified according to SOX11 expression as negative, light, and strong. CD34(+) microvessels, CD4(+) and CD8(+) T-lymphocytes, CD68(+) and CD163(+) macrophages, and the oncogene p53 expression were evaluated by immunohistochemistry. Moreover, STAT3 mRNA expression was analyzed by RNA-scope assay. Our results confirmedincreased angiogenesis in the sample of patients positive to SOX11 compared to the negative ones and demonstrated that angiogenesis and SOX11 expression positively correlate to a higher T-lymphocytes inflammatory infiltrate. On the contrary, angiogenesis and SOX11 expression negatively correlatewithmacrophage's inflammatory infiltrate and p53 expression. STAT3 mRNA expression level was not relevant concerning angiogenesis or SOX11 expression. Overall, our data indicate that, in MCL, SOX11 expression is associated with increased angiogenesis and a high CD4(+) and CD8(+) T-cell infiltration, which are not sustained by CD163(+) macrophages infiltrate and p53 expression. (C) 2020 The Authors. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.
机构:
Sir Charles Gairdner Hosp, Nedlands, WA 6009, Australia
PathWest Lab Med WA, Nedlands, WA, Australia
Univ Western Australia, Crawley, WA, Australia
Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USASir Charles Gairdner Hosp, Nedlands, WA 6009, Australia
Cheah, Chan Yoon
Seymour, John F.
论文数: 0引用数: 0
h-index: 0
机构:
Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia
Univ Melbourne, Parkville, Vic 3052, AustraliaSir Charles Gairdner Hosp, Nedlands, WA 6009, Australia
Seymour, John F.
Wang, Michael L.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USASir Charles Gairdner Hosp, Nedlands, WA 6009, Australia
机构:
Humanitas Gavazzeni, Oncol Unit, Bergamo, ItalyHumanitas Gavazzeni, Oncol Unit, Bergamo, Italy
Cortelazzo, Sergio
Ponzoni, Maurilio
论文数: 0引用数: 0
h-index: 0
机构:
Ist Sci San Raffaele, Pathol Unit, Milan, Italy
Ist Sci San Raffaele, Unit Lymphoid Malignancies, Milan, ItalyHumanitas Gavazzeni, Oncol Unit, Bergamo, Italy
Ponzoni, Maurilio
Ferreri, Andres J. M.
论文数: 0引用数: 0
h-index: 0
机构:
Ist Sci San Raffaele, Unit Lymphoid Malignancies, Milan, Italy
Ist Sci San Raffaele, Med Oncol Unit, Milan, ItalyHumanitas Gavazzeni, Oncol Unit, Bergamo, Italy
Ferreri, Andres J. M.
Dreyling, Martin
论文数: 0引用数: 0
h-index: 0
机构:
Univ MunchenGrosshadern, Med Klin 3, Munich, GermanyHumanitas Gavazzeni, Oncol Unit, Bergamo, Italy
机构:
Univ Virginia, Sch Med, Div Hematol Oncol, Charlottesville, VA 22908 USA
Univ Virginia, Sch Med, Ctr Canc, Charlottesville, VA 22908 USAUniv Virginia, Sch Med, Div Hematol Oncol, Charlottesville, VA 22908 USA
Williams, Michael E.
Dreyling, Martin H.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Munich, Dept Med 3, Univ Hosp Grosshadern, Munich, GermanyUniv Virginia, Sch Med, Div Hematol Oncol, Charlottesville, VA 22908 USA
Dreyling, Martin H.
Kahl, Brad S.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Wisconsin, Dept Med, Madison, WI USAUniv Virginia, Sch Med, Div Hematol Oncol, Charlottesville, VA 22908 USA
Kahl, Brad S.
Leonard, John P.
论文数: 0引用数: 0
h-index: 0
机构:
Cornell Univ, Dept Med, Weill Med Coll, New York, NY 10021 USAUniv Virginia, Sch Med, Div Hematol Oncol, Charlottesville, VA 22908 USA
Leonard, John P.
O'Connor, Owen A.
论文数: 0引用数: 0
h-index: 0
机构:
NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USAUniv Virginia, Sch Med, Div Hematol Oncol, Charlottesville, VA 22908 USA
O'Connor, Owen A.
论文数: 引用数:
h-index:
机构:
Press, Oliver W.
Wilson, Wyndham H.
论文数: 0引用数: 0
h-index: 0
机构:
NCI, NIH, Bethesda, MD 20892 USAUniv Virginia, Sch Med, Div Hematol Oncol, Charlottesville, VA 22908 USA